Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Kansas
mi
from
Kansas City, KA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Kansas
mi
from
Kansas City, KA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
mi
from
Lexington, KY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Boston University
mi
from
Boston, MA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Dartmouth Medical Center
mi
from
Lebanon, NH
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Dartmouth Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
mi
from
Albany, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
DENT Neurologic Institute
mi
from
Amherst, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
DENT Neurologic Institute
mi
from
Amherst, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Nathan S. Kline Institute for Psychiatric Research
mi
from
Orangeburg, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Nathan S. Kline Institute for Psychiatric Research
mi
from
Orangeburg, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University
mi
from
Beachwood, OH
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University
mi
from
Beachwood, OH
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Butler Hospital Memory & Aging Program
mi
from
Providence, RI
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Butler Hospital Memory & Aging Program
mi
from
Providence, RI
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
USF Health Byrd Alzheimer's Institute
mi
from
Tampa, FL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
USF Health Byrd Alzheimer's Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
New York Univ. Medical Center
mi
from
New York, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
New York Univ. Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Roper St. Francis Healthcare
mi
from
North Charleston, SC
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Roper St. Francis Healthcare
mi
from
North Charleston, SC
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of British Columbia, Clinic for Alzheimer's Disease and Related Disorders Program
mi
from
Vancouver,
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of British Columbia, Clinic for Alzheimer's Disease and Related Disorders Program
mi
from
Vancouver,
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Georgetown University
mi
from
Washington,
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Howard University
mi
from
Washington,
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Howard University
mi
from
Washington,
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Pacific Neuroscience Med Grp
mi
from
Oxnard, CA
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Pacific Neuroscience Med Grp
mi
from
Oxnard, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Yale University ADRU
mi
from
New Haven, CT
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Yale University ADRU
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Brain Matters Research
mi
from
Delray Beach, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Brain Matters Research
mi
from
Delray Beach, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Roskamp Institute
mi
from
Sarasota, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Roskamp Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Compass Research
mi
from
The Villages, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Compass Research
mi
from
The Villages, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Premiere Research Institute
mi
from
West Palm Beach, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Premiere Research Institute
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Boston Center for Memory
mi
from
Newton, MA
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Boston Center for Memory
mi
from
Newton, MA
Click here to add this to my saved trials